These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 33057153)

  • 1. Pan-cancer driver copy number alterations identified by joint expression/CNA data analysis.
    Wang G; Anastassiou D
    Sci Rep; 2020 Oct; 10(1):17199. PubMed ID: 33057153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Copy number losses of oncogenes and gains of tumor suppressor genes generate common driver mutations.
    Besedina E; Supek F
    Nat Commun; 2024 Jul; 15(1):6139. PubMed ID: 39033140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CNApp, a tool for the quantification of copy number alterations and integrative analysis revealing clinical implications.
    Franch-Expósito S; Bassaganyas L; Vila-Casadesús M; Hernández-Illán E; Esteban-Fabró R; Díaz-Gay M; Lozano JJ; Castells A; Llovet JM; Castellví-Bel S; Camps J
    Elife; 2020 Jan; 9():. PubMed ID: 31939734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of candidate tumor driver genes using a fully integrated Bayesian approach.
    Yang J; Wang X; Kim M; Xie Y; Xiao G
    Stat Med; 2014 May; 33(10):1784-800. PubMed ID: 24347204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Focal chromosomal copy number aberrations identify CMTM8 and GPR177 as new candidate driver genes in osteosarcoma.
    Both J; Krijgsman O; Bras J; Schaap GR; Baas F; Ylstra B; Hulsebos TJ
    PLoS One; 2014; 9(12):e115835. PubMed ID: 25551557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific genomic regions are differentially affected by copy number alterations across distinct cancer types, in aggregated cytogenetic data.
    Kumar N; Cai H; von Mering C; Baudis M
    PLoS One; 2012; 7(8):e43689. PubMed ID: 22937079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ProcessDriver: A computational pipeline to identify copy number drivers and associated disrupted biological processes in cancer.
    Baur B; Bozdag S
    Genomics; 2017 Jul; 109(3-4):233-240. PubMed ID: 28438487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of driver copy number alterations in diverse cancer types and application in drug repositioning.
    Zhou W; Zhao Z; Wang R; Han Y; Wang C; Yang F; Han Y; Liang H; Qi L; Wang C; Guo Z; Gu Y
    Mol Oncol; 2017 Oct; 11(10):1459-1474. PubMed ID: 28719033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probability distribution of copy number alterations along the genome: an algorithm to distinguish different tumour profiles.
    Esteves L; Caramelo F; Ribeiro IP; Carreira IM; de Melo JB
    Sci Rep; 2020 Sep; 10(1):14868. PubMed ID: 32913269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of tumor suppressors and oncogenes from genomic and epigenetic features in ovarian cancer.
    Wrzeszczynski KO; Varadan V; Byrnes J; Lum E; Kamalakaran S; Levine DA; Dimitrova N; Zhang MQ; Lucito R
    PLoS One; 2011; 6(12):e28503. PubMed ID: 22174824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pan-cancer analysis of copy number changes in programmed death-ligand 1 (PD-L1, CD274) - associations with gene expression, mutational load, and survival.
    Budczies J; Bockmayr M; Denkert C; Klauschen F; Gröschel S; Darb-Esfahani S; Pfarr N; Leichsenring J; Onozato ML; Lennerz JK; Dietel M; Fröhling S; Schirmacher P; Iafrate AJ; Weichert W; Stenzinger A
    Genes Chromosomes Cancer; 2016 Aug; 55(8):626-39. PubMed ID: 27106868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent patterns of DNA copy number alterations in tumors reflect metabolic selection pressures.
    Graham NA; Minasyan A; Lomova A; Cass A; Balanis NG; Friedman M; Chan S; Zhao S; Delgado A; Go J; Beck L; Hurtz C; Ng C; Qiao R; Ten Hoeve J; Palaskas N; Wu H; Müschen M; Multani AS; Port E; Larson SM; Schultz N; Braas D; Christofk HR; Mellinghoff IK; Graeber TG
    Mol Syst Biol; 2017 Feb; 13(2):914. PubMed ID: 28202506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of druggable cancer driver genes amplified across TCGA datasets.
    Chen Y; McGee J; Chen X; Doman TN; Gong X; Zhang Y; Hamm N; Ma X; Higgs RE; Bhagwat SV; Buchanan S; Peng SB; Staschke KA; Yadav V; Yue Y; Kouros-Mehr H
    PLoS One; 2014; 9(5):e98293. PubMed ID: 24874471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinguishing somatic and germline copy number events in cancer patient DNA hybridized to whole-genome SNP genotyping arrays.
    Ha G; Shah S
    Methods Mol Biol; 2013; 973():355-72. PubMed ID: 23412801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The repertoire of copy number alteration signatures in human cancer.
    Tao Z; Wang S; Wu C; Wu T; Zhao X; Ning W; Wang G; Wang J; Chen J; Diao K; Chen F; Liu XS
    Brief Bioinform; 2023 Mar; 24(2):. PubMed ID: 36806386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome-wide somatic copy number alteration analysis and database construction for cervical cancer.
    Luo H; Xu X; Yang J; Wang K; Wang C; Yang P; Cai H
    Mol Genet Genomics; 2020 May; 295(3):765-773. PubMed ID: 31901979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of candidate cancer drivers by integrative Epi-DNA and Gene Expression (iEDGE) data analysis.
    Li A; Chapuy B; Varelas X; Sebastiani P; Monti S
    Sci Rep; 2019 Nov; 9(1):16904. PubMed ID: 31729402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The shaping and functional consequences of the dosage effect landscape in multiple myeloma.
    Samur MK; Shah PK; Wang X; Minvielle S; Magrangeas F; Avet-Loiseau H; Munshi NC; Li C
    BMC Genomics; 2013 Oct; 14():672. PubMed ID: 24088394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of recurrent focal copy number variations and their putative targeted driver genes in ovarian cancer.
    Zhang L; Yuan Y; Lu KH; Zhang L
    BMC Bioinformatics; 2016 May; 17(1):222. PubMed ID: 27230211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome-wide identification of significant aberrations in cancer genome.
    Yuan X; Yu G; Hou X; Shih IeM; Clarke R; Zhang J; Hoffman EP; Wang RR; Zhang Z; Wang Y
    BMC Genomics; 2012 Jul; 13():342. PubMed ID: 22839576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.